Filing Flows › 13F managers › SoftBank Group
SoftBank Group: 13F portfolio Q2 2026 and what copying it returned
SoftBank Group's 13F for the quarter ended 2026-06-30 (filed Aug 14, 2026): 30 common-share positions, $18.2B reported. Copying each 13F the day after it was filed returned +38.6% from Jun 2, 2022 to Nov 6, 2026, against +56.3% for SPY.
Copying the 13F
Each 13F bought at the close of the first trading day after it was filed and held, drifting, until the next one; value-weighted over the common-share positions with a price (91.6% of the portfolio on average); 16 filings since Nov 13, 2020. Price returns for the clone and SPY alike (no dividends, no costs). A 13F lists only US long positions at quarter end, reported up to 45 days later.
Largest holdings (2026-06-30)
| Ticker | Company | Weight | Value | Change in the quarter |
|---|---|---|---|---|
| INTC | Intel | 66.8% | $12.1B | unchanged |
| SYM | Symbotic | 9.8% | $1.8B | unchanged |
| TMUS | T-Mobile US | 9.2% | $1.7B | unchanged |
| WBTN | Webtoon Entertainment | 2.0% | $359M | unchanged |
| TEM | Tempus AI | 1.7% | $313M | unchanged |
| TSM | Taiwan Semiconductor Manufacturing | 1.5% | $270M | -71.5% |
| CHYM | Chime Financial | 0.6% | $104M | unchanged |
| QXO | QXO | 0.5% | $94.5M | unchanged |
| LIFE | Ethos Technologies | 0.3% | $56.8M | unchanged |
| COF | Capital One Financial | 0.3% | $55.5M | new |
| RXRX | Recursion Pharmaceuticals | 0.3% | $50.0M | unchanged |
| PACB | Pacific Biosciences of California | 0.2% | $34.4M | unchanged |
| YMM | Full Truck Alliance | 0.2% | $31.5M | unchanged |
| GSAT | Globalstar | 0.1% | $26.1M | unchanged |
| BETR | Better Home & Finance Holding | 0.1% | $17.3M | unchanged |
| SATL | Satellogic | 0.1% | $13.9M | -6.0% |
| AMBQ | Ambiq Micro | 0.1% | $13.2M | unchanged |
| NMRA | Neumora Therapeutics | 0.1% | $10.4M | unchanged |
| SEER | Seer | 0.1% | $8.5M | unchanged |
Biggest adds
- COF new
- LIF new
Biggest cuts
- XXI exit
- TSM -71.5%
- SATL -6.0%
Track record
Of 58 position changes scored in 57 separate decisions, 55.2% were on the right side of SPY over the next three months (Disclosures → Smart money).
Open in Disclosures → every quarter, the clone month by month, the smart-money record
Source: SEC Form 13F-HR, filer CIK 1065521. Not investment advice.